Health Condition 1: D509- Iron deficiency anemia, unspecified
Conditions
Interventions
Intervention1: Trial drug (Gudaadi Mandur): The proposed trial drug Gudaadi Mandoor 15-18mg /kg/day in two divided doses for 8 weeks
Control Intervention1: Group B:IFA: B. Control: IFA Tablets
Sponsors
National Institute of Ayurveda Jaipur
Eligibility
Inclusion criteria
Inclusion criteria: 1) Female subjects aged between 12-15 years. 2) Subjects with iron deficiency Pandu (Anemia) (Hb gm%: 7 gm% to 11.9 gm %). 3) Subjects whose parents are willing to give consent for clinical trial.
Exclusion criteria
Exclusion criteria: 1) Hemoglobin gm% 2) Subjects suffering from major systemic illness necessitating long term treatment. 3) Subjects with evidence of malignancy. 4) Subjects with concurrent serious hepatic dysfunction (defined as AST and/or ALT >3 times of the upper normal limit) or renal dysfunction (defined as S. creatinine >1.2mg/dl), uncontrolled pulmonary dysfunction (asthmatic and COPD patients)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in Hb%Timepoint: 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical Improvement in symptoms of anemia in adolescent girlsTimepoint: 8 weeks | — |
Countries
India
Contacts
Public ContactPriyanka Kumari
National institute of ayurveda, Jaipur
Outcome results
None listed